Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.

Chow D, Chen H, Glesby MJ, Busti A, Souza S, Andersen J, Kohrs S, Wu J, Koletar SL. Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS. 2009 Oct 23; 23(16):2133-41.

View in: PubMed

authors with profiles

Dominic Chow, MD, PhD, MPH

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support